drugset / Trial / NCT00126373
A Trial of Wellbutrin for Crohn's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators are testing the hypothesis that Wellbutrin (bupropion) can give a clinical remission in Crohn's disease.
Timeline
- Start
- 2005-05
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 150 mg | — |
| Subject | Bupropion | Small molecule | 300 mg | — |